ACCEL DIAGNOSTICS, LLC — Department of Health and Human Services SBIR Phase II: NHLBI

ACCEL DIAGNOSTICS, LLC — SBIR Phase II award from Department of Health and Human Services.

Amount
$727,427
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
SBIR · Phase II
Topic
NHLBI
NAICS
Place of performance
TX
Period

Description

Cardiovascular toxicityCVTxis a serious short and long term complication of many anti cancer chemotherapeutic regimensZamoranoLancellotti et alIn this PhaseSBIR submission to continue the development and validation of Accel Diagnosticsminimally invasiverapidcost effective and connected blood testthe pScreen CVTx TMfor the early detection and continuous of chemotheropy induced CVTx